Press Releases

Researchers at KIT combine laser-based series interconnection with vacuum processing of all solar cell layers – upscaling paves the way from lab to industry

The Colloquium Fundamentale at KIT dedicates live stream lectures to the Age of Human Life on Earth

Strengthening Competencies at Universities: Federal Research Ministry Funds E-learning for Researchers Communicating with the Media and Public

Technologies and Strategies for Sustainable Economy Were in the Focus of the 2021 Annual Celebration of KIT

Helmholtz-Zentrum Hereon is coordinating a 5.5 million Euro EU project in creating a platform for innovative corrosion protection technologies.

KIT and Partners Conduct Research into Inexpensive and Highly Efficient Thermal Storage Systems of the Next Generation

Jülich, 3 May 2021. If not before, then certainly since the first messenger RNA (mRNA) vaccines to combat the SARS CoV2 virus were approved in Germany, mRNA has become a recognized term even outside scientific circles. What is less well known is that mRNA can be used to produce much more than just vaccines. Around 50 different procedures for the treatment of diseases including cancer are already being studied in clinical trials. Scientists from the pharmaceutical company AstraZeneca, with the support of neutron researchers from Forschungszentrum Jülich, have now discovered how the subcutaneous administration of mRNA can be improved. The goal is for chronically ill patients to be able to self-administer the medication on a regular basis.

Water is a scarce resource in many of the Earth’s ecosystems. This scarcity is likely to increase in the course of climate change. This, in turn, might lead to a considerable decline in plant diversity. Using experimental data from all over the world, scientists from the Helmholtz Centre for Environmental Research (UFZ), the German Centre for Integrative Biodiversity Research (iDiv), and the Martin Luther University of Halle-Wittenberg (MLU) have demonstrated for the first time that plant biodiversity in drylands is particularly sensitive to changes in precipitation. In an article published in Nature Communications, the team warns that this can also have consequences for the people living in the affected regions. 

Julia Schnabel has joined Helmholtz Zentrum München as the head of the newly formed Institute of Machine Learning in Biomedical Imaging. The new institute will complement and link into the biomedical imaging and computational health research program at the Center. Julia’s appointment means Helmholtz Zentrum München has gained an outstanding internationally renowned talent in this interdisciplinary research field.

A new gene-editing technique can be used to correct mutations in muscle stem cells, paving the way for the first potential cell therapy for genetic muscle disorders. The ECRC team led by Professor Simone Spuler have published their findings in the journal "JCI Insight".